The Effect of Physiotherapy Integrated With Yoga and Mindfulness on Individuals With Fibromyalgia

This trial, registered at University Hospital Tübingen and currently enrolling, tests a new 8-week program called PhYoMind that blends physiotherapy techniques with yoga and mindfulness for people with fibromyalgia (FM). Fibromyalgia is a chronic condition marked by widespread pain, fatigue, sleep problems, and heightened stress reactivity — and no single treatment addresses all of these dimensions well. The PhYoMind approach is built on the idea that combining hands-on physical therapy with mind-body practices may calm an overactive nervous system and reduce the amplified pain signalling that characterises FM. Participants are randomly assigned either to the PhYoMind group (supervised plus home sessions) or to a home-exercise-only control group. The primary outcome the researchers care most about is disability — how much FM limits daily functioning — while secondary outcomes include autonomic nervous system markers such as heart rate variability (HRV), pain perception, stress biomarkers, fatigue, and sleep quality. The study is still active and not yet recruiting new participants, with results expected around May 2026. If effective, PhYoMind could offer a structured, scalable non-pharmacological option that simultaneously targets the neurological, physiological, and psychological burden of FM.

• Trial is pre-results: no efficacy or effect-size data are yet available from this registration record.
• Primary outcome is disability (functional limitation), reflecting the study team's view that reducing FM's impact on daily life is the most clinically meaningful target.
• Secondary outcomes span autonomic nervous system function (HRV-proxy), central sensitisation markers, perceived stress, fatigue, and sleep quality — indicating a multi-system physiological hypothesis rather than a purely symptomatic one.
• The 8-week intervention combines supervised physiotherapy sessions with structured home practice, allowing assessment of both therapist-delivered and self-managed components of the program.
• Adverse event monitoring and adherence tracking are pre-specified, signalling intent to evaluate safety and feasibility alongside efficacy.

This is a randomised controlled trial (RCT) with two arms: the PhYoMind integrative intervention (physiotherapy + yoga + mindfulness) versus a home exercise control condition. The intervention duration is 8 weeks and includes both supervised and home-based sessions. Primary outcome is disability; secondary outcomes include autonomic and central nervous system function, pain perception, stress, fatigue, and sleep quality, with adverse events and adherence also captured. Sample size, specific physiotherapy techniques, yoga/mindfulness protocols, and precise measurement instruments are not detailed in the available registration abstract (best-effort summary from ClinicalTrials.gov record NCT07145788).

Because this record is a trial registration rather than a published results paper, no outcome data, effect sizes, or safety signals can yet be evaluated — all findings above are inferred from design intent only. The absence of a sham or active-attention control (beyond home exercise) means it will be difficult to disentangle the effects of therapist contact time and expectation from the specific PhYoMind techniques. The home exercise control group may introduce heterogeneity in adherence that could obscure true between-group differences. A logical next experiment would be a fully blinded, dose-matched active comparator trial (e.g., physiotherapy alone vs. yoga/mindfulness alone vs. combined) to isolate which component drives any autonomic or disability benefits.

This trial sits at the intersection of autonomic regulation and chronic pain intervention, extending the mechanistic framework established by [§34], which demonstrates that trauma-exposed and chronic-pain populations show impaired vagally mediated HRV — precisely the autonomic signature PhYoMind aims to normalise through yoga and mindfulness. It parallels [§69], which examines whether specific manual therapy sequences can modulate autonomic nervous system function in healthy adults, providing a comparator for the physiotherapy component of PhYoMind in a pain-free population. The multi-system secondary outcome battery (HPA-axis stress markers, sleep, fatigue) also parallels the allostatic burden framing seen in [§93], which links periodontal inflammation to composite allostatic load — both studies treating chronic conditions as whole-body stress-dysregulation problems rather than localised pathologies. Finally, the psychophysiological biomarker approach mirrors the stratification logic of [§82], which profiles autonomic and stress signatures in irritable bowel syndrome, another central sensitisation condition where mind-body overlap is clinically relevant.

• The Impacts of Trauma Exposure on Emotion Regulation and 2 Vagally Mediated Heart Rate Variability
  Directly relevant mechanistic parallel: this article quantifies how chronic trauma/pain conditions impair vagally mediated HRV — the same autonomic outcome PhYoMind targets — making it essential context for interpreting any HRV changes the trial reports.
• Effect of a Sequence of Specific Manual Therapy Techniques Targeting the Autonomic Nervous System in Healthy Adults
  Tests the autonomic effects of specific manual therapy techniques (the physiotherapy component of PhYoMind) in healthy adults, offering a clean mechanistic baseline against which the FM trial's combined intervention can be compared.
• Distinct psychophysiological biomarkers and risk stratification models for irritable bowel syndrome with constipation (IBS-C) and diarrhea (IBS-D)
  Profiles psychophysiological and autonomic biomarkers in irritable bowel syndrome — another central sensitisation disorder — providing a comparative biomarker framework for assessing whether FM patients show distinct or overlapping autonomic stress signatures.
• Impact of Periodontal Inflammation on Allostatic Load
  Frames chronic inflammatory conditions through an allostatic load lens, directly relevant to interpreting the stress biomarker secondary outcomes in this FM trial and contextualising whether integrative interventions shift composite stress burden.
• Repeated whole-body cryostimulation promotes a blood pressure reduction at rest in healthy adult men
  Examines a non-pharmacological physical intervention (whole-body cryostimulation) on autonomic blood pressure regulation, offering a methodological comparator for how brief structured physical stressors can produce measurable ANS changes in clinical populations.